PROS1 and arrhythmogenic right ventricular cardiomyopathy: Secondly, the low rate of pathogenic genetic variants in our ARVC cohort did not allow for a genotype–phenotype correlation (i.e., mutated cardiac protein-specific autoantibodies); future studies on wider ARVC cohorts are needed for establishing a robust genotype–phenotype analysis.